Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q2 2025 Earnings Call Transcript August 9, 2025
Operator: Welcome to Crinetics Pharmaceuticals Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] I’d now like to turn the call over to Gayathri Diwakar, Head of Investor Relations. Please go ahead.
Gayathri Diwakar: Thank you, operator. Good afternoon, everyone, and thank you for joining us to discuss the second quarter 2025 results. Today on the call, we have Dr. Scott...
